BG101104A - New benzamide derivative, its preparation and use in pharmacuetical compositions - Google Patents

New benzamide derivative, its preparation and use in pharmacuetical compositions

Info

Publication number
BG101104A
BG101104A BG101104A BG10110497A BG101104A BG 101104 A BG101104 A BG 101104A BG 101104 A BG101104 A BG 101104A BG 10110497 A BG10110497 A BG 10110497A BG 101104 A BG101104 A BG 101104A
Authority
BG
Bulgaria
Prior art keywords
preparation
benzamide derivative
new benzamide
pharmacuetical compositions
pharmacuetical
Prior art date
Application number
BG101104A
Other languages
Bulgarian (bg)
English (en)
Inventor
Ralf Anderskewitz
Kurt Schromm
Ernst-Otto Renth
Franz Birke
Armin Fuegner
Hubert Heuer
Christopher Meade
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of BG101104A publication Critical patent/BG101104A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG101104A 1994-07-13 1997-01-04 New benzamide derivative, its preparation and use in pharmacuetical compositions BG101104A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4424714A DE4424714A1 (de) 1994-07-13 1994-07-13 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff
PCT/EP1995/002113 WO1996002496A1 (fr) 1994-07-13 1995-06-03 Nouveau compose chimique, sa preparation et son utilisation en tant que medicament

Publications (1)

Publication Number Publication Date
BG101104A true BG101104A (en) 1998-04-30

Family

ID=6523048

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101104A BG101104A (en) 1994-07-13 1997-01-04 New benzamide derivative, its preparation and use in pharmacuetical compositions

Country Status (25)

Country Link
US (1) US5686496A (fr)
EP (1) EP0770058A1 (fr)
JP (1) JPH10502646A (fr)
KR (1) KR970704674A (fr)
CN (1) CN1152303A (fr)
AU (1) AU2736895A (fr)
BG (1) BG101104A (fr)
BR (1) BR9508395A (fr)
CA (1) CA2194886A1 (fr)
CO (1) CO4410185A1 (fr)
CZ (1) CZ8297A3 (fr)
DE (1) DE4424714A1 (fr)
EE (1) EE9700065A (fr)
FI (1) FI970095A (fr)
HR (1) HRP950363A2 (fr)
HU (1) HUT76827A (fr)
IL (1) IL114572A0 (fr)
MX (1) MX9700245A (fr)
NO (1) NO970123D0 (fr)
PE (1) PE35196A1 (fr)
PL (1) PL318114A1 (fr)
SK (1) SK1897A3 (fr)
WO (1) WO1996002496A1 (fr)
YU (1) YU45395A (fr)
ZA (1) ZA955781B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486181B1 (en) 1992-08-28 2002-11-26 City Of Hope Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
US6191169B1 (en) 1992-08-28 2001-02-20 City Of Hope Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
EP0743064A1 (fr) * 1995-05-17 1996-11-20 Eli Lilly And Company Antagonistes des leucotriènes pour utilisation dans le traitement ou dans la prévention de la maladie d'Alzheimer
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19718334A1 (de) * 1997-04-30 1998-11-05 Boehringer Ingelheim Pharma Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ID24720A (id) 1997-12-12 2000-08-03 Novartis Ag Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis
DE19834713A1 (de) * 1998-07-31 2000-02-03 Boehringer Ingelheim Pharma Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6528491B2 (en) * 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
MXPA03006328A (es) * 2001-01-16 2004-04-05 Boehringer Ingelheim Pharma Uso de antagonista de ltb4 para tratamiento y/o prevencion de enfermedades causadas por aumento de expresion de genes de mucina.
US20040006092A1 (en) * 2001-08-31 2004-01-08 Neurochem, Inc. Amidine derivatives for treating amyloidosis
US20070105104A1 (en) * 2003-05-06 2007-05-10 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4)
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
CA2572898C (fr) * 2004-07-05 2010-04-20 Dong Wha Pharmaceutical Ind. Co., Ltd. Composition pour la prevention et le traitement de maladies inflammatoires allergiques
ATE481968T1 (de) * 2004-07-14 2010-10-15 Inflammation Res Ct Company Lt Verfahren zur hemmung von tumormetastasierung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
EP0625138B1 (fr) * 1992-02-05 1999-06-02 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Nouveaux derives de l'amidine, leur fabrication et leur application en tant que medicaments ayant un effet antagoniste a ltb4

Also Published As

Publication number Publication date
CZ8297A3 (en) 1997-09-17
PE35196A1 (es) 1996-09-05
CO4410185A1 (es) 1997-01-09
NO970123L (no) 1997-01-10
WO1996002496A1 (fr) 1996-02-01
FI970095A0 (fi) 1997-01-10
NO970123D0 (no) 1997-01-10
PL318114A1 (en) 1997-05-12
US5686496A (en) 1997-11-11
FI970095A (fi) 1997-01-10
CA2194886A1 (fr) 1996-02-01
HU9700060D0 (en) 1997-02-28
AU2736895A (en) 1996-02-16
JPH10502646A (ja) 1998-03-10
HUT76827A (en) 1997-11-28
BR9508395A (pt) 1997-12-23
SK1897A3 (en) 1997-08-06
ZA955781B (en) 1996-02-22
KR970704674A (ko) 1997-09-06
YU45395A (sh) 1997-12-05
IL114572A0 (en) 1995-11-27
MX9700245A (es) 1997-05-31
EE9700065A (et) 1997-08-15
EP0770058A1 (fr) 1997-05-02
CN1152303A (zh) 1997-06-18
DE4424714A1 (de) 1996-01-18
HRP950363A2 (en) 1997-08-31

Similar Documents

Publication Publication Date Title
BG101104A (en) New benzamide derivative, its preparation and use in pharmacuetical compositions
GB2256138B (en) Topical terbinafine compositions
IS1812B (is) Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra
CA2134977A1 (fr) Compositions refrigerantes
AU2002213975A1 (en) Novel anticholinergic agents that can be used as medicaments and method for the production thereof
IL136503A0 (en) Adamantane derivatives
PL340906A1 (en) Adamantane derivatives
IL113657A0 (en) Pharmaceutical composition based on guar gum
GB2289472B (en) CRT adhesive composition and CRT obtained by the use thereof
EP0753997A4 (fr) Composition de cellulose, sa preparation et son utilisation dans un lipide
HU9602798D0 (en) Benzamide derivative, compositions containing said derivative and use thereof
ZA971892B (en) Compositions and use of benzamides and nicotin-amides as anti-inflammatory agents
HUP0003478A3 (en) Synergistic fungicidal compositions, their use and process for their preparation
BG101401A (en) Cisaspide extended release oral compositions
HUT77375A (hu) Enterokinetikus hatású benzamidszármazékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására
IL115029A0 (en) 2,3-bridged 1,4-dihydropyridines their preparation and use
ZA949874B (en) B3-adrenergic agents, benzodioxole dicarboxylates and their use in pharmaceutical compositions.
IL109438A0 (en) 3-Quinolyl-substituted dihydropyridines, processes for their preparation and their use in pharmaceutical compositions
ZA902245B (en) Azolylethylcyclopropanes,the preparation thereof and the use thereof as crop protection agents
GB9420616D0 (en) Method, compositions and use
PL317891A1 (en) Triple composition against hiv
AU4115796A (en) Iminooxymethylene anilides, process for preparing the same and their use
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
SG59910A1 (en) Rare earth oxysulphide composition a process for the preparation thereof and use thereof as a luninophore
AU3543797A (en) 1,2-substituted cycloalkane derivatives as thrombine inhibitors, a process for the preparation thereof and the use thereof in pharmaceutical formulations